Literature DB >> 9187661

A cluster of missense mutations at Arg356 of human steroid 21-hydroxylase may impair redox partner interaction.

S Lajic1, A Levo, A Nikoshkov, Y Lundberg, J Partanen, A Wedell.   

Abstract

Lesions in the gene encoding steroid 21-hydroxylase result in congenital adrenal hyperplasia, with impaired secretion of cortisol and aldosterone from the adrenal cortex and overproduction of androgens. A limited number of mutations account for the majority of mutated alleles, but additional rare mutations are responsible for the symptoms in some patients. A total of 11 missense mutations has previously been implicated in this enzyme deficiency. We describe two novel missense mutations, both affecting the same amino acid residue, Arg356. The two mutations, R356P and R356Q, were reconstructed by in vitro site-directed mutagenesis, the proteins were transiently expressed in COS-1 cells, and enzyme activity towards the two natural substrates, 17-hydroxyprogesterone and progesterone, was determined. The R356P mutant reduced enzyme activity to 0.15% towards both substrates, whereas the R356Q mutant exhibited 0.65% of normal activity towards 17-hydroxyprogesterone, and 1.1% of normal activity towards progesterone. These activities correspond to the degrees of disease manifestation of the patients in whom they were found. Arg356 is located in a region which recently has been implicated in redox partner interaction, by modelling the structure of two other members of the cytochrome P450 superfamily. Of the 11 previously described missense mutations, three affect arginine residues within this protein domain. With the addition of R356P and R356Q, there is a clear clustering of five mutations to three closely located basic amino acids. This supports the model in which this protein domain is involved in redox partner interaction, which takes places through electrostatic interactions between charged amino acid residues.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9187661     DOI: 10.1007/s004390050436

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  10 in total

1.  Characterization of novel missense mutations in CYP21 causing congenital adrenal hyperplasia.

Authors:  Tiina Robins; Christine Bellanne-Chantelot; Michela Barbaro; Sylvie Cabrol; Anna Wedell; Svetlana Lajic
Journal:  J Mol Med (Berl)       Date:  2006-11-21       Impact factor: 4.599

2.  Identification and functional characterization of a novel mutation P459H and a rare mutation R483W in the CYP21A2 gene in two Chinese patients with simple virilizing form of congenital adrenal hyperplasia.

Authors:  L Jiang; L L Song; H Wang; J L Wang; P P Wang; H B Zhou; X L Zhang
Journal:  J Endocrinol Invest       Date:  2011-07-12       Impact factor: 4.256

3.  Functional studies of two novel and two rare mutations in the 21-hydroxylase gene.

Authors:  M Barbaro; L Baldazzi; A Balsamo; S Lajic; T Robins; L Barp; P Pirazzoli; E Cacciari; A Cicognani; A Wedell
Journal:  J Mol Med (Berl)       Date:  2006-03-16       Impact factor: 4.599

4.  The residue E351 is essential for the activity of human 21-hydroxylase: evidence from a naturally occurring novel point mutation compared with artificial mutants generated by single amino acid substitutions.

Authors:  Nils Krone; Felix G Riepe; Joachim Grötzinger; Carl-Joachim Partsch; Jürgen Brämswig; Wolfgang G Sippell
Journal:  J Mol Med (Berl)       Date:  2005-04-14       Impact factor: 4.599

5.  A sequence variation in 3'UTR of CYP21A2 gene correlates with a mild form of congenital adrenal hyperplasia.

Authors:  S Menabò; A Balsamo; L Baldazzi; M Barbaro; A Nicoletti; V Conti; P Pirazzoli; A Wedell; A Cicognani
Journal:  J Endocrinol Invest       Date:  2011-04-26       Impact factor: 4.256

6.  Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency.

Authors:  Maria I New; Moolamannil Abraham; Brian Gonzalez; Miroslav Dumic; Maryam Razzaghy-Azar; David Chitayat; Li Sun; Mone Zaidi; Robert C Wilson; Tony Yuen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-28       Impact factor: 11.205

7.  Direct Molecular Diagnosis of CYP21A2 Point Mutations in Macedonian and Serbian Patients with 21-Hydroxylase Deficiency.

Authors:  Violeta Anastasovska; Tatjana Milenković; Mirjana Kocova
Journal:  J Med Biochem       Date:  2014-10-08       Impact factor: 3.402

8.  Functional and Structural Consequences of Nine CYP21A2 Mutations Ranging from Very Mild to Severe Effects.

Authors:  Débora de Paula Michelatto; Leif Karlsson; Ana Letícia Gori Lusa; Camila D'Almeida Mgnani Silva; Linus Joakim Östberg; Bengt Persson; Gil Guerra-Júnior; Sofia Helena Valente de Lemos-Marini; Michela Barbaro; Maricilda Palandi de Mello; Svetlana Lajic
Journal:  Int J Endocrinol       Date:  2016-09-19       Impact factor: 3.257

9.  Genotype-phenotype correlation study and mutational and hormonal analysis in a Chinese cohort with 21-hydroxylase deficiency.

Authors:  Chao Xu; Wenyu Jia; Xiangdeng Cheng; Hui Ying; Jing Chen; Jin Xu; Qingbo Guan; Xinli Zhou; Dongmei Zheng; Guimei Li; Jiajun Zhao
Journal:  Mol Genet Genomic Med       Date:  2019-04-09       Impact factor: 2.183

Review 10.  The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency.

Authors:  Duarte Pignatelli; Berta L Carvalho; Aida Palmeiro; Alberto Barros; Susana G Guerreiro; Djuro Macut
Journal:  Front Endocrinol (Lausanne)       Date:  2019-07-04       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.